Kratko priopćenje

https://doi.org/10.20471/may.2022.58.02.14

Daridorexant

Vjekoslav Peitl orcid.org/0000-0003-4163-6411 ; Department of Psychiatry, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia; School of Medicine, Catholic University of Croatia, Zagreb, Croatia
Darko Vlahović ; Department of Psychiatry, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia

Sažetak

Daridorexant belongs to a class of drugs known as dual orexin receptor (OX1R and OX2R) antagonists. It achieves its function by blocking the binding of wake-promoting neuropeptides orexins. This novel mechanism is believed to turn down overactive wakefulness and as we know so far, most other treatments for insomnia can be sedating.

Ključne riječi

Daridorexant

Hrčak ID:

284581

URI

https://hrcak.srce.hr/284581

Datum izdavanja:

23.10.2022.

Posjeta: 1.339 *